Fu Dejian, Gong Wanbao, Bao Xiaomin, Yang Bo, Wang Feng, Qiao Yubing, Wu Yuanjiang, Chen Guangzhen, Sun Weixun, Xiao Qiongzhi, Zou Wenbo, Fang Ning
Department of Cardiovascular, The People's Hospital of Zigui County, Yichang 443600, China.
Department of Cardiovascular, Changyang Tujia Autonomous County People's Hospital, Yichang 443000, China.
Nutr Res Pract. 2024 Aug;18(4):511-522. doi: 10.4162/nrp.2024.18.4.511. Epub 2024 May 27.
BACKGROUND/OBJECTIVES: The study examined the association between homocysteine and diabetes mellitus in patients with H-type hypertension and assessed the possible effect modifiers.
SUBJECTS/METHODS: This cross-sectional study included 1,255 eligible participants in the 'H-type Hypertension Management and Stroke Prevention Strategic International Science and Technology Innovation Cooperation Project' among rural Chinese people with H-type hypertension. A multivariate logistic regression model was used to evaluate the relationship between homocysteine and diabetes mellitus.
The mean level of total homocysteine (tHcy) in the diabetes mellitus population was 19.37 μmol/L, which was significantly higher than the non-diabetic patients (18.18 μmol/L). When tHcy was analyzed as a continuous variable, the odds ratio (OR) of diabetes was 1.17 (95% confidence interval [CI], 1.01-1.35; per interquartile range). When tHcy was stratified according to the quintile, the ORs for diabetes were 2.86 (95% CI, 1.22-6.69) in the highest quintile (tHcy ≥ 20.60 μmol/L) compared to the reference group (tHcy < 12.04 μmol/L). When tHcy was grouped by 15 μmol/L and 20 μmol/L, patients with tHcy ≥ 20 μmol/L had a significantly ( = 0.037) higher risk of diabetes (OR, 2.03; 95% CI, 1.04-3.96) than in those with tHcy < 15 μmol/L. Subgroup analysis showed that the tHcy-diabetes association was unaffected by other variables.
In this study of rural Chinese people with H-type hypertension, the tHcy levels showed a positive association with diabetes mellitus. This independent association is unaffected by other potential risk factors.
背景/目的:本研究探讨了H型高血压患者同型半胱氨酸与糖尿病之间的关联,并评估了可能的效应修饰因素。
对象/方法:这项横断面研究纳入了1255名符合条件的参与者,他们来自“中国农村H型高血压管理与脑卒中预防战略国际科技创新合作项目”中的H型高血压患者。采用多因素logistic回归模型评估同型半胱氨酸与糖尿病之间的关系。
糖尿病患者群体中总同型半胱氨酸(tHcy)的平均水平为19.37μmol/L,显著高于非糖尿病患者(18.18μmol/L)。将tHcy作为连续变量分析时,糖尿病的比值比(OR)为1.17(95%置信区间[CI],1.01 - 1.35;每四分位数间距)。当根据五分位数对tHcy进行分层时,最高五分位数(tHcy≥20.60μmol/L)的糖尿病OR值为2.86(95%CI,1.22 - 6.69),与参照组(tHcy < 12.04μmol/L)相比。当tHcy按15μmol/L和20μmol/L分组时,tHcy≥20μmol/L的患者患糖尿病的风险显著(P = 0.037)高于tHcy < 15μmol/L的患者(OR,2.03;95%CI,1.04 - 3.96)。亚组分析表明,tHcy与糖尿病的关联不受其他变量影响。
在这项针对中国农村H型高血压患者的研究中,tHcy水平与糖尿病呈正相关。这种独立关联不受其他潜在危险因素的影响。